Morishige, Tomohiro <br/><br/>
Mutants of lymphotoxin-α with augmented cytotoxic activity via TNFR1 for use in cancer therapy.  [electronic resource] 

 -  Cytokine  Feb 2013 
 - 578-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0023 
<br/><br/><label>Standard No.: </label>10.1016/j.cyto.2012.11.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Caspases--metabolism<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Electron Spin Resonance Spectroscopy<br/>Enzyme Activation--drug effects<br/>Humans<br/>Isoelectric Point<br/>Kinetics<br/>Lymphotoxin-alpha--chemistry<br/>Models, Molecular<br/>Molecular Sequence Data<br/>Mutant Proteins--chemistry<br/>NF-kappa B--metabolism<br/>Neoplasms--drug therapy<br/>Protein Binding--drug effects<br/>Receptors, Tumor Necrosis Factor, Type I--chemistry